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Snml'nal~ 
We have recently reported that on human B lymphocytes,  membrane IgM (mlgM) associates 
with a heterodimer of 47- and 37-kD polypeptides,  the 47-kD subunit being encoded by the 
rob-1 gene. We show here that expression of rob-l, both at the mRNA and the protein level, 
is not restricted to IgM + B cells but can also be found in IgM- pre-B cells and mlgM-IgG + 
B cells. Membrane forms of IgD and IgG, isolated from freshly isolated human B cells and B 
cell lines, are expressed together with heterodimeric protein structures biochemically similar to 
the mlgM-associated  polypeptides,  and these were shown to comprise the products of the rnb-1 
and B29 genes, or homologous genes. Finally, all three classes of antigen receptors are linked 
to protein kinases, capable ofphosphorylating the Ig-associated heterodimers. Our findings provide 
insight in the structural organization of the different antigen receptors on human B cells and 
have implications for their function. 
B  cell ontogeny is characterized by the subsequent expres- 
sion of different antigen receptors. Initially, maturation 
of committed progenitors to CD19+# -  pre-B cells is an- 
tigen independent, but as Ig molecules appear at the cell sur- 
face, differentiation  is arrested unless ligand binds to these 
receptors  (1-4).  On pre-B cells that synthesize #  H  chains 
but have not yet rearranged their L chain locus, a minority 
of the produced # chains is expressed at the cell membrane 
in association with the )~5/VpreB pseudo-L chain complex 
(5-9). As maturation progresses, so-called virgin B cells can 
be discerned that have successfully rearranged a conventional 
L chain gene, which enables them to express membrane IgM 
(mlgM)  1 as antigen receptor.  On mature B cells, mlgM is 
coexpressed  with  idiotypicaUy  identical  mlgD  molecules 
(10-14).  Recognition of antigen elicits signals that lead to 
cellular proliferation  and secretion of soluble forms of the 
receptors  that can act, in concert with components of the 
nonspecific immunological system, as effector molecules. In 
t Abbreviations used in this paper: BCR, B cell receptor; B-LCL, B-lym- 
phoblastic cell line; IPB, immunoprecipitation buffer; mlgM, membrane 
immunoglobulin  M; RT, room temperature. 
these activated B cells, membrane expression oflgD is termi- 
nated. During the secondary immune response the majority 
of responding cells are memory B cells that express and se- 
crete Ig of other isotypes than M and D, i.e., G, E, and A 
(2). Based on the qualities of their Fc portions and differ- 
ences in valency, the secreted forms of the different Ig classes 
exhibit distinct effector functions. To date, however, it is un- 
known to what extent the membrane-expressed forms of the 
five classes of antigen receptors differ in their coupling to 
intraceUular signaling  pathways. 
Recently, we have shown that mlgM on human B cells 
is noncovalently associated with a disulfide-linked dimer com- 
prising glycoproteins of 47 and 37 kD (15, 16). These mole- 
cules were demonstrated to be newly defined B cell antigens 
(16) that are both membrane exposed and substrates for serine- 
and threonine-kinase activity in vivo (15). mAb raised against 
a synthetic peptide (17) identified the 47-kD component as 
the product of the human homologue of the mb-I gene (16, 
18), and we have more recently found that the 37-kD subunit 
is encoded by the human homologue of the B29 gene (19, 
Mason et al.,  manuscript in preparation). 
These findings  were largely consistent  with reports  re- 
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brane expression of transfected mlgM in murine plasmacy- 
toma cells  was  shown  to  require  the  association with  a 
heterodimer that contains products of the mb-I and B29 genes 
(20-26). The B29 component of the dimer associated with 
IgD was initially believed to be linked to a protein encoded 
by a gene other than rob-1 (21, 22, 27),  but recent studies 
by Venkitaraman et al. (28) show that ~, % oe, and e H chains 
can all assemble with transfected rob-1 gene products at the 
cell surface of murine B29 + plasmacytoma cells. 
In this study we have analyzed the composition of the 
mlgM, mlgD, and mlgG receptor complexes  as they natu- 
rally occur on normal human B cells and transformed human 
B cell lines.  We show that all isotypes are associated with 
disulfide-linked heterodimers comprising products of the mb-I 
and B29 genes, or closely homologous genes. Moreover,  to- 
gether with the antigen receptors of/z, 8, or 3/isotypes, pro- 
tein kinases can be isolated that have specificity for the respec- 
tive Ig-associated  dimers. 
Materials and Methods 
Cells 
The/t-CD10+CD19 + pre-B cell line NALM-16 (29) and the 
pre-B cell line NALM-6 (29, 30), which expresses ~ H chain at 
the cell surface in association with the ~,5/VpreB psendo-L chain 
complex (7), the mIgM  + Burkitt lymphoma cell lines Dandi and 
Ramos, the mlgG  + lymphoblastic cell line EB4B, and the plas- 
macytoma cell line TH, recently generated at the author's institute 
(31),  were analyzed. IgD §  cells were sorted on  a  FACStar  | 
(Becton Dickinson Immunocytometry Systems,  San Jose, CA) out 
of a B cell population that had been transformed in vitro by EBV. 
This polyclonal B-lymphoblastic cell line (B-LCL) expresses high 
levels of mlgD and mlgM, and also secretes vast amounts of IgG. 
All cell lines were routinely cultured in IMDM supplemented  with 
5% FCS and antibiotics. Peripheral B cells were freshly isolated 
from tonsils of healthy donors. 
Antibodies 
mAbs specific for human/z chain (CLB-MH15) and 3' chain 
(CLB-MH16) were obtained  from the CLB (Amsterdam), and mAb 
and anti-/~  chain was from Southern Biotechnology  Associates, Inc. 
(Birmingham, AL). The mAb HM47, reactive with the human 
mb-1 gene product, was raised as described  in detail elsewhere (17). 
B29 antiserum was obtained by immunization of a rabbit with a 
synthetic peptide representing amino acids 215-228 of the predicted 
COOH terminus of the murine B29 polypeptide (19, Mason et 
al., manuscript in preparation). Purified mAbs were coupled cova- 
lently to CNBr-activated sepharose 4B beads (Pharmacia, Uppsala, 
Sweden). The B29 antiserum was coupled noncovalently to pro- 
tein A-CL4B sepharose beads (Pharmacia). 
Immunofluorescence Analyses 
Ceils were permeabillzed  by incubation in PBS/0.01% (wt/vol) 
digitonin for 5 min at room temperature (RT) and then fixed in 
1% paraformaldehyde  in PBS for 5 rain on ice. Permeabilized or 
untreated cells were stained using the described mAb specific for 
human IgM, IgD, IgG, and rob-l, followed by HTC-conjugated 
goat anti-mouse Ig (G26M17; CLB). All antibodies were diluted 
in PBS supplemented with 0.5% BSA. Samples were analyzed on 
a FACScan  |  (Becton Dickinson Immunocytometry Systems). 
RNA  Isolation and Northern Blot Analysis 
Total RNA was isolated from 107 cells per cell line using the 
guanidium-thiocyanate-phenol-chloroform  extraction procedure  de- 
scribed by Chomczynski and Sacchi (32). 15 #g RNA per sample 
was subjected to electrophoresis on a 0.8% agarose gel under de- 
naturing conditions using formaldehyde and blotted  to Gene- 
ScreenPlus (New England Nuclear, Boston, MA). The blot was 
prehybridized in hybridization buffer containing dextran sulphate 
for 1 h at 65~  and then incubated with radioactive probe and 
32p-labded by random priming (Boehringer Mannheim Biochem- 
icals, Mannheim, Germany) for 16-20 h at 65~  The blot was 
washed with 2x  SSC/0.1% SDS once at KT and twice at 65~ 
followed  by a wash with 0.1x  SSC/0.1% SDS at 65~  for 30 min, 
and exposed to Kodak X-Omat AK 5 film at  -70~  Radiola- 
beled probe was removed  from the blot by incubation with 0.01x 
SSC/0.01% SDS at 90~  for 20 min. The same blot was hybrid- 
ized with following probes in this order. (a) The complete 1.2-kb 
human rob-1 cDNA, flanked  by EcoRI sites (a kind gift of Dr. M. 
Reth, Max Planck  Institut ffir Immunbiologie,  Freiburg, Germany). 
(b) A 1.2-kb EcoRI germline genomic fragment containing human 
C~1, C,2, and C~a exons (33) (from Dr. T. H. Rabbitts, Cam- 
bridge, UK). (c) A 1.3-kb NarI-NaeI cDNA fragment encoding 
human Cvl, Csz, and C~3 domains (from Dr. T. Honjo, Osaka 
University, Osaka, Japan). 
Biochemical Analyses 
Radiolabeling.  For cell surface radioiodination, 20-100  x  106 
viable cells were suspended  in PBS and labeled with 1 mCi Nat2SI 
(Amersham Co.,  Amersham, UK)  using  lactoperoxidase as  a 
catalyst. 
Iramunoprecipitation.  Labeled  or unlabeled cells were washed 
three times in serum-free medium and lysed in immunoprecipita- 
tion buffer (IPB), consisting of 0.01 M triethanolamine-HC1, pH 
7.8, 0.15 M NaC1, 5 mM EDTA, 1 mM PMSF, 0.02 mg/ml ovomu- 
coid trypsin inhibitor, 1 mM TLCK, 0.02 mg/ml leupeptin, sup- 
plemented with 1% digitonin as detergent. Nuclear debris was re- 
moved by centrifugation for 15 min at  13,000 g. Lysates were 
centrifuged for 30 min at 100,000 g and precleared by three incu- 
bations with 30 p.1 of  a 10% (vol/vol)  suspension  of  protein A-CL4B 
Sepharose beads (Pharmada) coated with normal mouse Ig. Spedfic 
immunoprecipitation  was carried out two subsequent times for 2 h. 
Immunoprecipitates were subjected to five washes in IPB with 
digitonin and resuspended in sample buffer. 
In Vitro Phosphorflation.  Immunoprecipitates from unlabeled 
cells were washed three times in EDTA-free IPB, and suspended 
in 25 #1 kinase buffer containing 25 mM Hepes, 100 mM NaC1, 
10 mM MgCh, and 10 mM MnClz (pH 7.4). Next, 5-10/~Ci 32p 
3"ATP (Amersham  Co.) was added and incubated for 10 rain at RT. 
After the kinase reaction had been stopped with IPB containing 
10 mM EDTA, the immunoprecipitates were washed twice and 
suspended in sample buffer. 
Reprecipitation.  The in vitro phosphoryhted Ig-associated  mol- 
ecules were dissociated  from the mlg chains by incubation of anti- 
Ig immunoprecipitation for I h on ice in 200 ~1 IPB, supplemented 
with 1% NP-40 (in the case of mIgM) or with 0.1% SDS, fol- 
lowed by addition of NP-40 to 2% (in the case ofmlgD or mlgG). 
Proteins in the supernatants were reduced and alkylated  before im- 
munoprecipitation as follows: addition of 0.2% SDS, incubation 
for 5 rain at 68~  addition of 2 mM dithiothreitol, incubation 
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followed by incubation for 20 rain at KT. The ehates were diluted 
with 5 vol oflPB with 1.5% NP-40, 100 #g myoglobin was added 
as carrier protein,  and the ehates were precleared with Sepharose 
beads coated with normal mouse Ig, before immunoprecipitation 
with specific antibody. 
Enzyme Treatment.  Immunoprecipitates were resuspended in 50 
#1 of 0.05 M sodium acetate, pH 5.5, 0.9% NaCI,  0.1%  CaC12, 
I mM PMSF, and 0.02 mg/ml trypsin inhibitor, and then incubated 
for 3 h at 37~  with Neuraminidase type VIII (Sigma Chemical 
Co., St.  Louis, MO) at 0.1 U/sample. 
Gel Electrophoresis of Proteins.  Samples  were analyzed by SDS- 
PAGE in 5-15 % polyacrylamide gradient gels, using a modification 
of the Laemmli procedure, under reducing conditions (5%/$-mer- 
captoethanol  in SDS sample buffer) or nonreducing  conditions 
(1 mM iodoacetamide in SDS sample buffer).  IEF was done ac- 
cording  to  O'I~arrell (34), using  ampholytes  (LKB, Bromma, 
Sweden) ofpI 3.5-10, 4-6, 5-8, and 9-11 as 10:1:1:1. Samples were 
run in the first dimension from base to acid. IEF was followed by 
SDS-PAGE in the second dimension on 5-15% SDS-polyacrylamide 
gradient gels. Autoradiography took place at  -70~  using Kodak 
X-Omat AK5 film in combination with intensifier screens (Cronex; 
DuPont Co., Wilmington,  DE). 
KOH Treatment.  The dried gel was rehydrated and incubated 
for 2 h at 60~  in 1 M KOH. After removal of the KOH by five 
subsequent wash steps within 2 h, the gel was dried and reexposed. 
Hgm~ 1.  Expression  of  the mM 
gene is not restricted to mlgM  + B 
cells. Total KNA (15 #g per lane), 
isolated from the  B  cell lines 
NALM-6 (lane I),  NALM-16 
(lane 2), Dandi (lane 3), Ramos 
(lane 4),  a  mlgM+IgD +  LCL 
(lane 5), EB4B  (lane  6), TH (lane 
7), and the T cell line HPB-ALL 
(lane 8) was hybridized with 32p. 
labeled probes specific  for # and 
3' H chains and mb-1. Arrows in- 
dicate the positions  of  the 28S (top) 
and 18S (bottom) ribosomal  RNA 
subunits, respectively. 
Results 
Expression of  the mb-I Cene in B Cells at Different Maturation 
Stages.  Evaluation  of the rob-1 mKNA gene in human  B 
cell lines representing different stages of B cell development 
(Fig.  1) showed that this gene is transcribed in the pre-B cell 
lines NALM-16,  which does not transcribe the #  H  chain 
gene (Fig.  1,  lane 2),  and NALM-6,  known  to  synthesize 
#  H  chains that appear at the cell surface in association with 
the pseudo-L chain complex (7) (Fig.  1, lane I).  The more 
mature mIgM-expressing Burkitt lymphoma lines Daudi and 
Ramos, and a polyclonal lymphoblastic call line (LCL) con- 
taining mIgM+IgD + B cells,  all had high levels ofmb-1  ex- 
pression (Fig.  1, lanes 3-5, respectively). The cell line EB4B, 
which contains 3' but not #  mKNA, clearly expressed rob-1 
mKNA (Fig.  1, lane 6). The human plasmacytoma call line 
TH (31),  which synthesizes Ig L chains  (data not shown), 
showed very low detectable levels of rob-1 mKNA  (Fig.  1, 
lane 7),  whereas the T  cell line HPB-ALL was negative for 
#,  3",  and  rob-1 expression  (Fig.  1,  lane 8). 
Expression of  the mb-I Protein.  Protein expression, analyzed 
by indirect immunofluorescence staining using mAbs specific 
for rob-l, #,/~, and 3' H chains was in agreement with mKNA 
expression. As the rob-1 protein is a typical type I transmem- 
brahe molecule (18),  the mAb does not react with intact B 
calls but only stains  permeabilized cells (Fig,  2). The pre-B 
cell line NALM-16 did not express #  protein either  at  the 
cell surface (Fig. 2 A, left) or intracellularly (data not shown), 
but did react with the anti-mb-I mAb (Fig. 2 A, right). The 
pre-B cell line NALM-6 showed low membrane expression 
of #  protein,  which is in agreement with a report by Kerr 
et al., (7), while rob-1 protein was clearly present (Fig.  2 B). 
Strong reactivity of the anti-rob-1 antibody could be demon- 
strated with the mlgM §  mlgM+IgD +, and mlgM-IgG + 
cell  lines  (Fig.  2,  C,  D,  and  E,  respectively).  On  the 
mlgM +mlgD +LCL,  IgG  was  not  membrane  expressed 
(Fig. 2 D), despite the fact that this line secretes vast amounts 
of this isotype (data not shown). Weak staining of the plas- 
macytoma line TH for mb-I  was observed (Fig.  2 F) while 
T  cells  and T  cell lines  were negative (data  not  shown). 
C 
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Figure 2.  Expression  of rob-1 
protein  is  not  restricted  to 
mlgM + B lymphocytes. FACS  | 
analysis of B cell lines NALM-16 
(A), NALM-6 (/3), Daudi (C), 
mIgM+IgD  + LCL  (D), EB4B 
(E), and TH (F), either untreated 
(/eft) or ~rmeabil~ (~#0. The 
cells were stained with  mAbs 
specific for ~ (  .... ), ~ (  .... ), 
3`H chains  (- -- --), rob-/(  .....  ), 
or medium alone (  ). 
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Receptor  Complexes.  The finding that expression of mb-1 nei- 
ther at mKNA  nor protein level was restricted  to mIgM- 
expressing B cells suggested that the mb-I gene product might 
participate in B cell antigen receptor complexes of different 
isotypes. Analysis of the mlgM complex (BCR#),  isolated 
from tonsil B cell populations, by IEF, followed by SDS-PAGE 
under reducing conditions, yielded a characteristic pattern, 
reminiscent of the  one  reported  for  the  mlgM  complex 
originating from B cell lines (16).  The/~  H  chains (Fig.  3 
Figure  3.  Membrane  forms  of 
IgM, IgD, and IgG on tonsil B cens 
are  expressed  in association  with 
similar dimeric complexes.  MIgM 
(a), mlgD (b), and mlgG complexes 
(c) were separately immunoprecipi- 
tated  from  a  digitonin  lysate  of 
surface-iodimted  tonsil B cells. The 
immunoprecipitates,  either  mock 
treated or neuraminidase treated (~ 
and right, reslx'ctively),  were ana- 
lyzed  by IEF followed by SDS-PAGE 
under  reducing conditions. In  all 
panels,  the numbered spots repre- 
sent the Ig H chains (I), Ig L chains 
(4), and the heterodimeric compo- 
nents  (2 and 3).  In c,  the 45-kD 
dimeric component was ordy detect- 
able on a longer exposed autoradio- 
gram (not shown here). 
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forms migrate as multiple spots ~30 kD (no. 4). The mIgM- 
associated molecules of 47 and 37 kD (nos. 2 and 3), being 
the products of rob-1 (16) and B29 (Mason et al., manuscript 
in preparation), respectively, have both relatively acidic, but 
different, pIs. Removal of sialic acids by treatment with neur- 
aminidase (Fig.  3 a, right) decreased their charge heteroge- 
neity but did not eliminate the difference in pI. 
Membrane IgD (Figs. 3 b and 4 a) and IgG (Figs.  3 c and 
4 b) immunoprecipitates from tonsiUar B ceUs and B cell lines 
contained, in addition to the various H  and L chains (nos. 
1 and 4, respectively), pairs of rdatively acidic polypeptides 
(nos. 2 and 3) that are, as judged by Mr and pI, very similar 
between mIgM, mIgD, and mIgG complexes. The dimer iso- 
lated with mIgD consisted of subunits of "~49 and ,u36 kD 
(Figs.  3 b and 4 a), whereas 45- and 35-kD molecules were 
precipitated in association with mIgG (Fig.  3 c and 4 b). A 
striking and consistent difference  between the 47-kD mIgM- 
associated molecule (from both peripheral B cells and B call 
lines) and the 49- and 45-kD components associated with 
mIgD or mlgG, respectively, is that the latter two polypep- 
tides were weakly labeled by radioactive iodine. In the mlgG 
isolate from tonsil B calls, the 45-kD molecule was not de- 
tectable after normal exposure of the autoradiogram (Fig.  3 
c), but was clearly discernable in IgG immunoprecipitates from 
the EB4B Cell line. Moreover, in the mIgG immunoprecipi- 
tare from the cell line EB4B, an additional molecule of ",~31 
kD was detected (Fig.  4 b, arrow) that, to judge from its pI 
after neuraminidase treatment and since it complexed with 
mIgG under nonreducing conditions (data not shown), prob- 
ably represents an alternative L chain species. Furthermore, 
two discrete proteins of low molecular mass were immuno- 
precipitated with mIgG from this cell line (Fig.  4  b,  nos. 
5 and 6).  These proteins have masses of 15 and 10 kD and 
are not sialylated since their pIs were not affected by neur- 
aminidase treatment.  So far these molecules could not be 
demonstrated on other B cells,  either surface iodinated or 
metabolically labeled. 
Molecules Associated  with rMgM, mlgD, and mlgG Are Sub- 
stratesfor Protein  Kinase  Activity.  We analyzed by an in vitro 
Figure 4.  The 49- and 45-kD 
components of the  mIgD- and 
mlgG-assodated heterodimers  are, 
compared  with their  disulfide-linked 
partners, labeled  with poor inten- 
sity The mIgD (a) and mIgG (b) 
antigen receptor complexes were 
isolated from digitonin lysates of 
surface-labeled  mIgM  +  IgD § LCL 
and EB4B cells, respectively.  The 
immunopredpitates,  either  mock  or 
neuraaftm'da~  treated  (left  and rigkt, 
respectively) were separated ac- 
cording to pI and Mr. Numbered 
spots represent  Ig H chains (1), Ig 
L chains  (4), and the beterodimeric 
components  (2 and 3). The 31-kD 
protein  (b, arrow)  most  likely  depicts 
an  alternative L  chain species, 
whereas  the 15- and 10-kD  polypep- 
tides (b, nos. 5 and 6) are of un- 
known identity. 
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plex  contains  a  protein  kinase 
with specificity for the 47-  and 
37-kD  heterodimeric  subunits. 
The mIgM receptor complex was 
isolated from a digitonin lysate of 
3sS-methionine-labeled  Dandi 
cells. The immunoprecipitate was 
phosphorylated by an in vitro ki- 
nase  reaction using either unla- 
beled ATP (lane A) or ~/[32P]ATP 
(lanes B and C). The samples were 
separated  by  SDS-PAGE  under 
reducing (lane A  and B) or non- 
reducing (lane  C) conditions. 
kinase assay whether proteins contained within the human 
BCRs are substrates for kinase activity. BCR/~ was isolated 
by immunoprecipitation  from a digitonin lysate of Daudi cells 
that had been labeled biosynthetically with 3SS-methionine. 
In the presence of unlabeled ATP, mature and precursor forms 
oflg H and L chains were detected (Fig. 5, lane A), whereas 
the Ig-associated heterodimer was only visible after longer 
exposure (not shown). However, after incubation with radio- 
active ATP the presence of previously undetected phospho- 
proteins of 37, 47, 70, 100, 113, and 133 kD was visualized 
(Fig. 5, lane B). Under nonreducing conditions, the 37- and 
47-kD molecules proved to be the IgM-associated heterodi- 
meric subunits,  as they migrated as a single band of 80-85 
kD (Fig. 5, lane C). The intensity of Ig H and L chain bands 
was not altered in case radioactively labeled ATP was used, 
which corroborates the specificity of the in vitro kinase reac- 
tion. Phosphorylation of both 47- and 37-kD molecules was 
resistent to potassium hydroxide treatment (see Fig. 6), im- 
plying  that  these  polypeptides  contain  phosphotyrosine 
residues (35), which was confirmed by phospho-amino acid 
analysis (Brouns  et al.,  manuscript in preparation). 
To further elucidate the structural relationship between the 
different  antigen receptor classes, we investigated  whether 
the mlgD and mlgG complexes (designated as BCR/$ and 
BCRy)  also contain  kinase  activity  specific for  the  H 
chain-associated  heterodimers.  Indeed, the heterodimers as- 
sociated with/~, 8, and 3r H chains can all be phosphorylated 
by kinases apparently present in the immunoprecipitates (Fig. 
6, a, b, and c, lanes A, respectively). KOH treatment of the 
gel significantly reduced the labeling of most of the immu- 
noprecipitated phosphoproteins,  whereas the intensity of the 
Ig-associated dimers was hardly diminished (Fig. 6, a, b, and 
c, lanes B), suggesting that they can all be phosphorylated 
on tyrosine residues. 
Heterodimers Associated with mlgM,  mlgD,  and mlgG All 
Contain Components  Reactive with rob-1 and 1329  Antibodies.  In 
Figure 6.  The mlgM-, mlgD-, and mlgG-associated  heterodimers serve 
as substrates for associated kinases and react with rob-l-  and B29-spedfic 
antibodies. From unlabded, digitonin-solubilized,/~+ Dandi (a), poly- 
clonal tonsil (b) or 3, + EB4B B cells (c),/~, ~,  and 3' H  chains,  respec- 
tively, were immunoprecipitated, phosphorylated in vitro, and analyzed 
under reducing conditions by SDS-PAGE. After exposure (lanes A), the 
gel was treated with KOH, dried, and reexposed (lanes B). From half of 
the samples, the Ig-associated heterodimers were eluted with IPB con- 
taining SDS and/or NP-40 (see Materials and Methods). Immunoprecipi- 
tation was performed out of these duates, which had been reduced and 
alkylated, with the HM47 mAb (lanes C) and the B29 antiserum (lanes D). 
agreement with  the  reprecipitation  studies  from  surface- 
iodinated B  cells,  also from in vitro  phosphorylated im- 
munoprecipitates,  the 47-  and 37-kD  components of the 
mlgM-associated  heterodimer could be defined as rob-1 and 
B29 gene products, respectively (Fig. 6 a, lanes C and D). 
Next to the 47-kD subunit, the rab-1 mAb also reacted with 
a protein of 41-kD, previously shown to be a differentially 
glycosylated form of the same polypeptide (Fig. 6 a, lane C) 
(16). A similar explanation  may hold for the B29 immuno- 
precipitate that contains a 35-kD protein in addition to the 
37-kD band (Fig. 6 a, lane D). Analysis of the mlgD- and 
mlgG-associated dimers,  originating from tonsil B (Fig. 6 
b) and EB4B cells (Fig. 6 c), demonstrated that the anti-rob-1 
mAb and B29 antiserum were also reactive with the higher 
and lower molecular mass dimeric subunits, respectively (Fig, 
6,  b and c, lanes C  and D, respectively). 
Discussion 
Expression of mlgM at the surface of murine plasmacy- 
toma cells depends on its association with a disulfide-linked 
dimer of 34- and 39-kD proteins (20-22,  27, 36, 37) encoded 
by the rub-1 (18) and B29 (19) genes (23-25).  Wienands et 
al. (22) reported that the smaller 35-kD subunit in the mlgD- 
associated heterodimer is not equivalent to mb-I protein and 
that the murine mlgD receptor complex therefore differs from 
the mlgM complex. This report was based on their observa- 
tion that mb-1 mRNA could not be detected in mlgD-catrying 
myeloma cells. Later, it became evident that the mlgD mole- 
cules appearing on the surface of mb-1 -  plasmacytoma cells 
represent  alternatively processed forms of mlgD, which do 
not depend on association with the mb-1 gene product (38). 
Moreover, the 35-kD molecule of the heterodimer associated 
1516  Structural Analysis of Human B Cell Antigen Receptor Complexes with the complexed form of mlgD has now been shown to 
be the product of the mb-I gene, or a dosdy related gene 
(26, 38). These findings were recently extended by Venkitar- 
aman et al. (28), who demonstrated by transfection studies 
that the membrane forms of #, ~, % o~, and e H chains can 
all associate with heterodimers comprising the mb-I and B29 
polypeptides. However, none of the reports so far exclude 
the possibility that on primary B cells the heterodimers as- 
sociated with different Ig isotypes accommodate proteins en- 
coded by alternative forms of the mb-I and or B29 genes. 
In the present study we show that the membrane forms 
of human/z,/~, and 3' H chains, on freshly isolated tonsillar 
B cells and leukemic B cell lines, are expressed together with 
membrane-spanning  heterodimers that are very similar in terms 
of their biochemical properties (Figs. 3 and 4) and associated 
protein kinase activity (Fig. 6). The structural relationship 
between the mlgM-, mlgD-, and mlgG-associated hetero- 
dimers was confirmed by the reactivity of their components 
with the rob-1 and B29 antibodies (Fig. 6). Nevertheless, differ- 
ences were found in the susceptibility to radioiodination be- 
tween the distinct isotype-associated rob-l-like molecules, and 
more stringent detergent conditions were required to dissociate 
the dimers from mlgD and mlgG than from mlgM. The 
variation in molecular mass between the Ig-associated dimers 
may,  since carbohydrate moieties attribute substantially to 
the observed molecular mass of both dimeric subunits (15, 
16), have less significance. Indeed, transfection experiments 
in the routine system have indicated that the nature of the 
associated mlg class determines the degree of glycosylation 
of the mb-I gene product (28,  38).  Thus, we have shown 
a high degree of structural relatedness between the hetero- 
dimers associated with different H  chain isotypes,  but the 
identity of these molecules has yet to be proven. 
The sequence of the human mb-I cDNA predicts a protein 
with cytoplasmatic, transmembrane, and proximal extracel- 
lular domains that are highly homologous to the same regions 
of the murine rob-1 molecule (Reth et al.,  and van Noesel 
et al., unpublished data). However, a part of the extracellular 
domain, which spans the Ig-like protein loop, differs dearly 
between man and mouse. Transfection experiments by Horn- 
bach et al. (23) indicated that the C.3 and C.4 and trans- 
membrane domains of the # H chain are critical for interac- 
tion with the rob-1 or B29 gene product. These findings 
suggest that if isotype-related differences between the mb-I 
(and B29) molecules exist, they may be found in the extracel- 
lular or transmembrane domains. Since both the anti-rob-1 
mAb and the B29 antiserum we used recognize epitopes at 
the COOH termini, they may not be able to detect these 
differences. The murine mb-I gene at the genomic level (39) 
includes all sequence information found in the previously 
cloned cDNA  (18),  but Southern blot  analysis of mouse 
genomic DNA with the mb-I cDNA suggested the existence 
of an additional rob-l-related gene (39). Therefore, it cannot 
be ruled out that the mb-I proteins described here are derived 
from distinct, but closely related genes. Alternatively, different 
transcripts may be derived from the same gene by differential 
mKNA processing, although as yet only one type of human 
mb-I cDNA has been isolated and no obvious differences in 
mRNA size were detected in cell lines expressing different 
receptor isotypes. 
When the BCR is compared with the TCR (40, 41) and 
the FcRIII (42-45), two receptors that are involved in im- 
munological recognition processes,  the most conspicuous 
difference is the lack of a ~" homologue. Compared with the 
~" chains, the heterodimeric molecules have a different struc- 
tural organization as they belong to the Ig supergene family 
(18, 19, 36, 39). On the other hand, they both contain, in 
common with CD3-%  -6,  -~', and the 3' and 3  chains of 
the rat mast cell Fc receptor,  a conserved sequence motif of 
six identically spaced cytoplasmic amino acids (36, 46). The 
significance of the ~" protein was emphasized recently by Irving 
and Weiss (47), who showed that a number of signaling events 
that normally result from TCR ligation can be evoked by 
the cytoplasmic domain of the ~" chain only. In the in vitro 
kinase assay shown here, as well as in metabolic labeling ex- 
periments (data not shown), we have not found any evidence 
for the presence of ~'-like components in any of the three mIg 
complexes. In this respect, the isolation of the two additional 
low molecular mass molecules together with mIgG from 
EB4B ceils (Fig. 4 b) was intriguing, but as yet we have not 
been able to demonstrate any reactivity with anti-~"  peptide 
sera (data not shown). Additionally, the 10- and 15-kD pro- 
teins are, contrary to the ~'chain, monomeric structures that 
are easily surface iodinated and have until now not been de- 
tected in phosphorylated form. The notion that a ~" homo- 
logue does not contribute to the BCR is supported by the 
reconstitution experiments by Ventikaraman et al. (28), which 
established that the presence of the mb-I and B29 gene prod- 
ucts are sultident for mlg surface expression in nonlymphoid 
cells. 
We demonstrate that on mature peripheral human B cells, 
the BCR~, BCR~, and BCR'y are connected with protein 
kinases,  which must at  least  be related  as judged by the 
similarity of their substrates  (Fig. 6).  The murine mIgM- 
and mIgD-associated heterodimers have been shown to be 
phosphorylated on tyrosine residues upon antigen receptor 
ligation (48) or upon stimulation of permeabilized cells with 
aluminum fluoride (27). Moreover, murine mIgM was found 
to be closely linked to the src-family kinase p56 lyn (49). 
Since after KOH treatment the labeling intensity of the Ig- 
associated heterodimers is hardly diminished, the presence of 
protein tyrosine kinases in the human B cell antigen receptor 
complexes, comprising different H chain isotypes, is also sug- 
gested. The proposed composition of the BCR classes has 
implications for their function. The results obtained in this 
study, combined with the recent findings of Venkitaraman 
et al.  (28),  suggest that the membrane-expressed forms of 
the different isotypes may couple to the intracellular com- 
partment in essentially the same way via identical rob-1 and 
B29 molecules. However, the end result of antigen receptor 
triggering at different B cell maturational stages may very 
well be distinct, depending on the availability of intracellular 
substrates. 
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